Reason: CGMP Deviations: Potential Glass and Silicone particulates in product
Distributed: Nationwide in the USReason: Failed Impurities/Degradation Specifications: Out-of-specification test results.
Distributed: Nationwide in the USAReason: CGMP Deviations: potential presence of Burkholderia cepacia complex
Distributed: Nationwide in the USAReason: Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Distributed: MNReason: an out of specification result obtained during routine stability testing for Impurities. There is a remote possibility that use of this product could cause a medically reversible or transient adverse health consequences.
Distributed: The product was distributed nationwide within the United States.Reason: Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Distributed: nationwideReason: Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
Distributed: nationwideReason: Failed Impurities/Degradation Specifications: Out of Specification (OOS) result in the repackaged product for Related Compounds (Impurities) at the 6-month time point.
Distributed: Nationwide in the USAReason: Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.
Distributed: USA nationwide.Reason: CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
Distributed: Nationwide in the USA